UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 8 )*
Thermo Fisher Scientific Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common
--------------------------------------------------------------------------------
(Title of Class of Securities)
883556102
----------------------------------
(CUSIP Number)
November 30, 2006
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
PAGE 1 OF 5 PAGES
CUSIP NO.883556102 13G PAGE 2 OF 5 PAGES
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dodge & Cox 94-1441976
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
N/A
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California - U.S.A.
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
17,846,639
-----------------------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 195,700
OWNED BY -----------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 19,322,839
WITH -----------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
19,322,839
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.7%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IA
--------------------------------------------------------------------------------
PAGE 2 OF 5 PAGES
Item 1(a) Name of Issuer:
---------------
Thermo Fisher Scientific Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
------------------------------------------------
81 Wyman Street
P.O. Box 9046
Waltham MA 02454-9046
Item 2(a) Name of Person Filing:
----------------------
Dodge & Cox
Item 2(b) Address of the Principal Office or, if none, Residence:
-------------------------------------------------------
555 California Street, 40th Floor
San Francisco, CA 94104
Item 2(c) Citizenship:
------------
California - U.S.A.
Item 2(d) Title of Class of Securities:
-----------------------------
Common
Item 2(e) CUSIP Number:
-------------
883556102
Item 3 If the Statement is being filed pursuant to Rule 13d-1(b),
----------------------------------------------------------
or 13d-2(b), check whether the person filing is a:
--------------------------------------------------
(e) [X] Investment Advisor registered under section 203 of the
Investment Advisors Act of 1940
Item 4 Ownership:
----------
(a) Amount Beneficially Owned:
------------------------------
19,322,839
(b) Percent of Class:
---------------------
4.7%
PAGE 3 OF 5 PAGES
(c) Number of shares as to which such person has:
---------------------------------------------
(i) sole power to vote or direct the vote:
17,846,639
(ii) shared power to vote or direct the vote:
195,700
(iii) sole power to dispose or to direct the disposition of:
19,322,839
(iv) shared power to dispose or to direct the disposition of:
0
Item 5 Ownership of Five Percent or Less of a Class:
---------------------------------------------
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the
following [x].
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
----------------------------------------------------------------
Securities reported on this Schedule 13G are beneficially owned by
clients of Dodge & Cox, which clients may include investment
companies registered under the Investment Company Act and/or employee
benefit plans, pension funds, endowment funds or other institutional
clients.
Item 7 Identification and Classification of the Subsidiary Which Acquired
------------------------------------------------------------------
the Security Being Reported on By the Parent Holding Company:
-------------------------------------------------------------
Not applicable.
Item 8 Identification and Classification of Members of the Group:
---------------------------------------------------------
Not applicable.
Item 9 Notice of Dissolution of a Group:
--------------------------------
Not applicable.
Item 10 Certification:
-------------
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the
ordinary course of business and were not acquired for the purpose of
and do not have the effect of changing or influencing the control of
the issuer of such securities and were not acquired in connection
with or as a participant in any transaction having such purpose or
effect.
PAGE 4 OF 5 PAGES
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: December 8, 2006
DODGE & COX
By: /s/ THOMAS M. MISTELE
-----------------------------
Name: Thomas M. Mistele
Title: General Counsel & COO
PAGE 5 OF 5 PAGES